Viewing Study NCT04844606


Ignite Creation Date: 2025-12-26 @ 4:01 PM
Ignite Modification Date: 2025-12-29 @ 7:14 AM
Study NCT ID: NCT04844606
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2021-04-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module